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cardiovascular disease risks in older patients with
type 2 diabetes
Jui-Hua Huang1, Leih-Ching Tsai2, Yu-Chen Chang1,3 and Fu-Chou Cheng4*Abstract
Background: We investigated the effects of dietary calcium (Ca) and magnesium (Mg) intakes on cardiovascular
disease risks in older patients with diabetes.
Methods: In this cross-sectional study, 197 patients with type 2 diabetes aged 65 years and above were recruited.
The 24-h dietary recalls and 1-week self-reported typical dietary intake patterns were collected. The Ca and Mg
intakes of <67% of the recommended dietary allowance (RDA), 67%–100% of RDA, and >100% of RDA were defined
as low, moderate, and high Ca and Mg intakes, respectively. Anthropometric measurements were determined and
biochemical analysis of blood and urine was performed.
Results: Our data indicated that 60.9% and 87.3% of our patients were Ca and Mg intakes below RDA, respectively.
Patients whose Ca intake was high or low (81.2%) had significantly higher C-reactive protein (CRP) than those
whose Ca intake was moderate (p = 0.043). Furthermore, patients whose Mg intake was low (87.3%) had significantly
higher CRP than that of those who took adequate Mg (p = 0.025). The dietary Ca:Mg intake ratios were highly
correlated with CRP, platelet counts, and red blood cell distribution (p < 0.05). A dietary Ca:Mg intake ratio of 2.0–2.5
was significantly correlated to lower CRP levels (p = 0.013).
Conclusions: High or low calcium intake increases cardiovascular disease risks. We suggest that “moderate” intake
of 402–600 mg Ca/day (approximately 67%–100% of Taiwan RDA for Ca) and adequate Mg intake (or meeting RDA
for Mg) with Ca:Mg intake ratio of 2.0–2.5 are important for reducing cardiovascular disease risks in older patients
with diabetes.
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Diabetes is frequently associated with cardiovascular dis-
ease (CVD) and cardiovascular complications [1]. In gen-
eral, patients with diabetes have high risk for CVD, a major
death factor, particularly in older patients [2,3]. Inflamma-
tion also plays a key role in the pathogenesis and progres-
sion of CVD in patients with diabetes [4-6]. Diet, lifestyle,
and medical interventions may promote or retard inflam-
matory responses in diabetic management [7-9]. Low mag-
nesium (Mg) and calcium (Ca) intakes raise inflammatory
and CVD risks [10-12]. However, the effects of high Ca or* Correspondence: vc1035@gmail.com
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remain unclear.
Low Mg intakes are associated with increased inflamma-
tion and risk of type 2 diabetes and CVD [12-14]. A nation-
ally representative cross-sectional survey showed that
adults in the USA consuming Mg below the recommended
dietary allowances (RDAs) were more likely to have ele-
vated C-reactive protein (CRP), which may contribute to
CVD risks [12]. In rodents, the intake of an Mg-deficient
high-fat diet led to alterations in the insulin-signaling path-
way and increased insulin resistance [15]. In patients with
diabetes, low serum Mg levels were found to be associated
with macrovascular complication [16], and hypomagnes-
emia was arryhtmogenic [17]. In addition, low serum Mg
levels increased chronic inflammatory stress that could beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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with poor quality of sleep [18]. Dietary Ca intakes were also
reported to be associated with the modulation of inflamma-
tory stress and pathogenesis of CVD [11,19,20]. However,
whether high Ca intake decreases or increases the risk of
CVD remains controversial [11,20]. Zemel et al. [19] found
that dietary Ca suppresses oxidative and inflammatory
stress. A cross-sectional study showed that increased Ca in-
takes decreased the risk of several CVD risk factors [21]. In
contrast, in another study, increasing dietary Ca intake or
use of Ca supplementation was noted to raise myocardial
infarction risks [22]. Although Mg and Ca intakes are
closely related to inflammation and CVD risks, they also
interact and each antagonizes the other’s absorption in the
intestinal tract [23]. Mg is a natural physiologic Ca antagon-
ist. Therefore, varied Mg and Ca dietary intakes can alter
the absorption of Mg or Ca alone, and inappropriate Mg
and Ca dietary intakes can cause additional CVD risks.
The intestinal absorption of Ca or Mg may depend on
the amounts of Ca and Mg present in the diet [23]. There-
fore, owing to the nature of these intestinal interactions,
the dietary Ca:Mg intake ratio and the absolute amount of
Ca or Mg in the daily diet may be equally important in re-
ducing CVD risks. Recently, Dai et al. found that the im-
pact of Ca:Mg intake ratio on the risk of CVD had
significantly higher modifying effects than that of Ca or Mg
intake alone in Chinese populations [24]. In addition, the
United States Department of Agriculture (USDA) food sur-
veys from 1977 through 2008 showed a rise in the Ca:Mg
intake ratio, which coincided with the increased prevalence
and incidence of type 2 diabetes [25]. Therefore, the effects
of dietary Ca and Mg intakes on CVD risks may vary de-
pending on the dietary Ca:Mg intake ratio. Thus, the roles
of dietary Ca and Mg intakes and their ratio in the preven-
tion of CVD warrant further investigation.
Older patients with diabetes are at high risk for CVD
[2,3], and Mg deficiency is common in this population
[26,27]. Mg deficiency may be exacerbated by low Mg with
high or low Ca intakes [13,28], which may trigger inflam-
matory stress, contributing to the development of CVD
[13]. However, the effects of dietary Ca and Mg intakes on
CVD risk have not been intensively explored in older pa-
tients with diabetes. To date, numerous studies have dem-
onstrated correlations between Ca or Mg intakes alone
with CVD risk [10,29,30], but relatively few studies have
examined the potentially combined effects of dietary in-
takes of Ca and Mg on CVD risk [24]. The present study
was conducted to explore CVD risks in older patients with
type 2 diabetes with respect to their dietary Mg and Ca in-
takes and Ca:Mg intake ratios. Dietary intakes and lifestyle
data were obtained and assessed using questionnaires. In
addition, anthropometric measurements were determined
and biochemical analysis of blood and urine samples was
performed.Methods
Study design
The investigation employed a cross-sectional research
design targeting patients with type 2 diabetes aged 65 years
and above. Diabetes was diagnosed in the Endocrine and
Metabolism Clinic according to the guidelines of the
American Diabetes Association (ADA-1997) [31]. The in-
clusion criteria for patients were as follows: 1) type 2 dia-
betes for >6 months; 2) no change in any medications for
the past 3 months; 3) stable lifestyle for the past 3 months;
and 4) absence of heart failure, cirrhosis, current malig-
nancy, chronic renal failure, or clinically relevant infection
(CRP levels > 10 mg/L). Patients with signs of serious
deterioration in comprehension and memory were ex-
cluded. A total of 197 patients were included in the
study. This investigation was performed in compliance
with the Helsinki Declaration, and approved by the
Changhua Christian Hospital Institutional Review Board
(CCHIRB: 090419).
Assessment of dietary intakes, lifestyle, and body mass
index
Dietary intakes were assessed using 24-h recall and
7-day typical dietary intake by interview and dietary re-
cords [32,33]. During the interview, quantitative tools in-
cluding standard measuring spoons and cups, food
models, food pictures and photos, as well as traditional
household bowls, cups, and spoons were used to help
the elderly subjects properly estimate their dietary intake
[34]. Intakes of Ca, Mg, and other nutrients were analyzed
using Taiwan’s Nutrition Database and the EKitchen
nutritional analysis software (Nutritional Chamberlain
Line, Professional Edition, version 2001/2003, EKitchen
Inc, Taichung, Taiwan) [35]. In addition, data on potential
confounders, such as lifestyle factors, including physical
activity, smoking, and alcohol consumption, were collected
using a self-reported questionnaire. Anthropometric
measurements included height and weight. Body mass
index (BMI) was calculated as weight (kg)/height (m2).
Moderate nutrient intakes were defined as consumption
of 67% of RDA for that nutrient or 67% of its adequate
intake value (AI) [36]. In the present study, assessment
of Ca intakes was based on a previous RDA for Ca for
Taiwanese aged 65 years and above (600 mg/day), because
the Ca intake level for majority of older patients with
diabetes was below the current AI for Ca (1000 mg/day).
The Ca intakes were categorized as follows: 1) low: Ca
intakes <67% of RDA for Ca; 2) moderate: Ca intakes
approximately 67%–100% of RDA for Ca; and 3) high:
Ca intakes more than RDA for Ca [36]. In addition, as-
sessment of Mg intakes was based on RDA for Mg for
Taiwanese aged 65 years and above (350–360 mg/day
for older men and 300–310 mg/day for older women).
The Mg intakes were categorized as follows: 1) low: Mg
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approximately 67%–100% of RDA for Mg, and 3) high:
Mg intakes more than RDA for Mg [36].
Markers of inflammation and CVD risks
Inflammatory markers were measured by the hospital me-
dical laboratory (certified ISO15189) to assess CVD risk
and included high-sensitivity CRP [37], leukocyte counts
[38], platelet counts [39], and red blood cell distribution
width (RDW) [40]. The high-sensitivity CRP (CV <3.0%)
was measured by particle-enhanced turbidimetric immuno-
assay (Dimension, Siemens, Newark, USA). The CRP
levels of <1, 1–3, and >3 mg/L represented low, mode-
rate, and high CVD risk, respectively [37]. Patients with
clinically relevant infection (CRP levels >10 mg/L) were
excluded. In addition, blood leukocytes (CV <3.0%) and
platelets (CV <3.0%) were measured by the direct current
detection method (XT1800i, Sysmex, Kobe-shi, Hyogo,
Japan) and RDW was calculated. The subjects were
stratified into tertiles (low, medium, and high) based on
leukocyte counts, platelets, and RDW.
Renal functional measurements
The serum creatinine levels (CV <2%) were determined
by the alkaline picrate-kinetic method. The estimated
glomerular filtration rate (GFR) was calculated as eGFR
(mL/min/1.73 m2) (Simplified Modification of Diet in Renal
Disease (MDRD)) = 186 × serum creatinine−1.154 × Age−0.203
for men and 186 × serum creatinine−1.154 × Age−0.203 ×
0.742 for women, according to the formula recommended
by the Taiwan Society of Nephrology [41].
Statistical analysis
The categorical variables were analyzed by the chi-square
test, and the data are presented in number (n) and percent
(%). For continuous dependent variables, comparisons of
the means were analyzed by 2-tailed t-test (2 groups) or
one-way ANOVA followed by Scheffe’s multiple compari-
sons test, and the data are presented as mean ± SD. In
addition, the correlations of dietary Ca and/or Mg intakes
and markers of inflammation with CVD risks were exam-
ined by multivariate analyses, followed by Bonferroni’s
multiple comparisons test, and the data are presented
as adjusted mean ± standard error (SE). All the statis-
tical procedures were performed using SPSS 17.0 sta-
tistical software (SPSS Inc., Chicago, IL, USA), and a
p value <0.05 was considered statistically significant.
Results
The characteristics of the 197 older patients with type 2
diabetes are summarized in Table 1. Among all the
patients, 60.9% of the patients’ Ca intake was less than
the previous RDA (600 mg/day) and 87.3% patients’ Ca
intakes were below the current AI (1000 mg/day). Inaddition, 87.3% of the patients’ Mg intake was below
RDA, and the total energy, carbohydrate, fat, and Mg in-
takes were different between men and women (p ≦ 0.05).
The analyses were adjusted for potential confounders,
which included lifestyle factors such as physical activity,
smoking, and alcohol consumption (data not shown).
As shown in Table 2, the dietary Ca:Mg intake ratio
was significantly associated with the levels of CRP, plate-
lets, and RDW (p < 0.05). The subgroup with a Ca:Mg
intake ratio of 2.0–2.5 had significantly lower CRP and
RDW than the one with a Ca:Mg intake ratio of >3.6.
Moreover, the subgroup with a Ca:Mg intake ratio of
2.0–2.5 had a lower proportion of patients with ≥2 high
inflammatory markers, when compared with the other
subgroups. However, the dietary Ca:Mg intake ratio was
not significantly associated with leukocyte count. In
addition, the subgroup with a Ca:Mg intake ratio of 2.0–
2.5 presented a significantly higher Ca intake than those
with Ca:Mg intake ratios of ≤1.3 and 1.4–1.9. In con-
trast, the subgroup with a Ca:Mg intake ratio of 2.0–2.5
exhibited a significantly lower Ca intakes than the one
with a Ca:Mg intake ratio of >3.6. Moreover, the dietary
Ca:Mg intake ratio showed a marginal correlation with
Mg intakes (p = 0.099).
The relationships between CRP and dietary Ca or Mg
intake alone are shown in Figure 1. Dietary Ca intake
was significantly correlated to the CRP level (p = 0.038).
Moreover, patients consuming moderate amount of Ca
(402–600 mg Ca/day) had lower CRP than those con-
suming high amount of Ca, i.e. >600 mg Ca/day (0.9 ±
0.4 vs. 1.8 ± 0.3, p = 0.033). In addition, patients consum-
ing high or recommended amount of Mg (RDA for Mg
for healthy men and women in Taiwan above 65 years of
age is 350–360 and 300–310 mg/day, respectively) had a
lower CRP level than those consuming low amount of
Mg (0.8 ± 0.5 vs.1.9 ± 0.3, p = 0.012).
The correlations between different CRP levels (low,
moderate, and high CVD risks) and different Ca and Mg
intake levels (nine subgroups) were analyzed by chi-
square test. The findings showed that CRP levels were
correlated to dietary Ca and Mg intakes. Although some
cells had an expected count of <5, the Chi-square test
showed a statistically significant result (p = 0.001). The
above-mentioned nine subgroups with different levels of
Ca and Mg intakes were categorized as follows: 1) low
Ca and low Mg intakes; 2) low Ca and moderate Mg in-
takes; 3) low Ca and high Mg intakes; 4) moderate Ca
and low Mg intakes; 5) moderate Ca and moderate Mg
intakes; 6) moderate Ca and high Mg intakes; 7) high Ca
and low Mg intakes; 8) high Ca and moderate Mg intakes;
and 9) high Ca and high Mg intakes. In addition, the cor-
relations between different CRP levels (low, moderate, and
high CVD risks) and dietary Ca:Mg intake ratio were ex-
amined by one-way ANOVA. The results showed that the
Table 1 Characteristics of older adults with type 2 diabetes by gender
Variables Total (n = 197) Male (n = 90) Female (n = 107) P 4
Age (y) 72.1 ± 5.3 72.2 ± 5.4 72.1 ± 5.3 0.935
Diabetes medication
Oral hypoglycemic drug 138 (70.1) 65 (72.2) 73 (68.2) 0.542
Insulin and oral hypoglycemic drug 69 (29.9) 25 (27.6) 34 (31.8)
Glycated hemoglobin (%) 7.3 ± 1.3 7.4 ± 1.3 7.3 ± 1.3 0.534
Estimated GFR1 (ml/min) 71.2 ± 19.1 70.3 ± 19.1 71.9 ± 19.1 0.541
Body mass index (kg/m2) 25.3 ± 3.7 24.9 ± 3.4 25.6 ± 4.0 0.176
High-sensitivity CRP1 (mg/L)
<1 low cardiovascular risk 57 (28.9) 27 (30.0) 30 (28.0) 0.169
1–3 moderate cardiovascular risk 105 (53.3) 52 (57.8) 53 (49.5)
>3 high cardiovascular risk 35 (17.8) 11 (12.2) 24 (22.4)
Dietary intake
Total energy intake (kcal/day) 1583.7 ± 414.3 1765.3 ± 434.5 1424.8 ± 322.1 <0.001
Carbohydrate intake (% of energy) 60.9 ± 8.5 59.5 ± 8.5 62.1 ± 8.3 0.027
Protein intake (% of energy) 12.4 ± 2.6 12.5 ± 2.4 12.3 ± 2.8 0.464
Fat intake (% of energy) 26.7 ± 7.3 28.2 ± 7.5 25.3 ± 6.9 0.004
Calcium (mg/day) 556.9 ± 385.3 557.9 ± 319.1 556.0 ± 436.5 0.972
<AI 172 (87.3) 82 (91.1) 90 (84.1) 0.142
<a previous RDA1,2 120 (60.9) 53 (58.9) 67 (62.6) 0.593
Magnesium (mg/day) 218.4 ± 102.4 252.5 ± 112.8 188.6 ± 81.8 <0.001
<RDA3 172 (87.3) 72 (80.0) 100 (93.5) 0.005
1GFR: glomerular filtration rate, CRP: C-reactive protein, AI: adequate intake, RDA: recommended dietary allowance, EAR: estimated average requirement.
2A previous Taiwan RDA for Ca for healthy individuals above 65 years of age is 600 mg/day. Current Taiwan AI of Ca for healthy individuals above 65 years of age
is 1000 mg/day.
3Taiwan RDA for Mg for health individuals above 65 years of age is 350–360 mg/day for men and 300–310 mg/day for women.
4A p value <0.05 was considered statistically significant. Continuous data are presented as mean ± SD. Categorical data are presented as number (n) and
percent (%).
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CVD risk groups were 2.1 ± 1.3, 2.8 ± 1.8, and 3.0 ± 1.8,
respectively (p = 0.016).
The distribution of patients with high CVD risk
(CRP >3 mg/L) according to different levels of Ca and
Mg intakes (nine subgroups) is presented in Figure 2.
Among the patients with high CVD risk, 37.1% had low
Ca and low Mg intakes, 28.6% had high Ca and low Mg
intakes, 20.0% had high Ca and moderate Mg intakes, and
5.7% had low Ca and high Mg intakes. In addition, the
high Ca and high Mg intakes subgroup, moderate Ca and
moderate Mg intakes subgroup, and low Ca and moderate
Mg intakes subgroup each comprised 2.9% of the patients
with high CVD risk. No patients with high CVD risk con-
sumed a diet with moderate amount of Ca and low or
high amount of Mg. Furthermore, 97.1% of the high CVD
risk patients were found to consume high or low amount
of Ca and only 2.9% consumed moderate amount of Ca,
even when these patients were stratified by Mg intakes.
Among the high CVD risk patients who consumed low or
high amount of Ca, the percentage of patients who con-
sumed low amount of Mg was higher than that of patientswho consumed moderate to high amount of Mg (65.7%
vs. 31.5%).
Discussion
The effects of high or low Ca and low Mg intakes on
CVD risks in patients with diabetes have not been fully
elucidated. This cross-sectional study investigated the ef-
fects of dietary Ca and Mg intakes on CVD risk in older
patients with type 2 diabetes. Our data showed that (1)
the Ca intake in 60.9% of the patients was lower than
the previous RDA and the Mg intake in 87.3% of the pa-
tients was below RDA; (2) high or low Ca intake may
cause high CVD risks; (3) low Mg intakes were corre-
lated to high CVD risk; and (4) dietary Ca:Mg intake
ratio of 2.0–2.5 was correlated to low CVD risks.
Ca and Mg intakes in the older population
Ca and Mg are essential elements in human physiology
and are especially important in the biological functions
of the cardiovascular system [30,42]. However, in many
countries, it has been reported that the dietary Ca and
Mg intakes in the general population remain below
Table 2 Relationships of dietary Ca:Mg intake ratio and markers of inflammation and CVD risk in older patients with
diabetes
Quintiles of dietary Ca:Mg ratio
Variables ≤1.3 (n = 40) 1.4–1.9 (n = 39) 2.0–2.5 (n = 42) 2.6–3.6 (n = 38) >3.6 (n = 38) p4
Dietary Ca and Mg intake1
Calcium intake (mg/day)* 212.9 ± 179 312.8 ± 158.2 555.3 ± 219.0 700.6 ± 261.1 1060 ± 396.5 <0.001
Magnesium intake (mg/day) 223.9 ± 138.6 204.3 ± 96.9 251.6 ± 104.0 231.1 ± 90.7 193.7 ± 64.8 0.099
Markers of inflammation and cardiovascular risk2
High-sensitivity CRP (mg/L)† 1.8 ± 0.3 1.9 ± 0.4 1.2 ± 0.4 1.8 ± 0.4 2.7 ± 0.4 0.013
White blood cell (109 cells/L) 6.6 ± 0.3 6.2 ± 0.3 5.9 ± 0.3 6.8 ± 0.4 6.4 ± 0.4 0.200
Platelet (103/μL) 227.5 ± 11.0 203.4 ± 11.2 205.7 ± 11.3 235.5 ± 11.7 224.3 ± 11.7 0.046
Red blood cell distribution width (%)† 13.5 ± 0.2 13.6 ± 0.2 13.1 ± 0.2 13.7 ± 0.2 13.8 ± 0.2 0.032
Number of high inflammatory markers3
0 10(25.0) 17(43.6) 21(50.0) 12(31.6) 7(18.4) 0.002
1 14(35.0) 7(17.9) 18(42.9) 10(26.3) 16(42.1)
≥2 16(40.0) 15(38.5) 3(7.1) 16(42.1) 15(39.5)
1The comparisons of the means were analyzed by one-way ANOVA. *indicates significant difference in Ca intake between the subgroup with a ratio of 2.0–2.5 and
those with ratios of ≤1.3, 1.4–1.9, and >3.6 by Scheffe’s multiple comparisons test.
2The analyses were adjusted for sex, age, glycated hemoglobin, BMI, physical activity levels, smoking, alcohol consumption, and total energy, carbohydrate,
protein, and fat intake. The data are adjusted mean ± standard error (SE). †indicates significant difference in CRP and red blood cell distribution width between the
subgroup with a ratio of 2.0–2.5 and the one with a ratio of >3.6 by Bonferroni’s multiple comparisons test.
3Categorical variables were analyzed by chi-square test. The data are presented as number (n) and percent (%). The definition of high levels of the following four
inflammatory markers: CRP >3 (mg/L), white blood cell >6.5 (103/mm3), platelet >227.0 (103/μL), and red blood cell distribution width >13.6 (%).
4A p value of <0.05 was considered statistically significant.
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RDA for Ca for healthy individuals above 65 years of age
is 650–1300 mg/day [11,43,45]. In our data, the daily con-
sumption of Ca in older men and women with diabetes
was only 558 and 556 mg, respectively. Furthermore,
60.9% of the older patients with diabetes did not meet the
previous RDA for Ca (600 mg/day), and 87.3% of the pa-
tients did not meet the current AI for Ca (1000 mg/day).
The data from the National Health and Nutrition Exami-
nation Survey (NHANES) 2005–2008 indicate that most
of the Americans over 50 years of age (92–93%) did notFigure 1 Relationship between CRP and Ca or Mg intake alone. (1) CR
for sex, age, BMI, physical activity levels, smoking, alcohol consumption, tot
different levels of Ca intakes or Ca intakes for different levels of Mg intakes
considered statistically significant. *indicates significant differences between
comparisons test.meet the AI for Ca (1200 mg/day) [43]. Furthermore, the
data from the Nutrition and Health Surveys in Taiwan
(NAHSIT) 2005–2008 show that the average Ca intakes in
men and women over 50 years of age were 673 and
592 mg, respectively [46], suggesting that 82%–94% of
Taiwanese over 65 years of age, regardless of gender, did
not meet the previous RDA for Ca (600 mg/day) [46].
Moreover, it has been reported that dietary Mg intakes
below RDA are common in populations throughout the
world [43,44]. The general RDA for dietary Mg for healthy
individuals above 65 years of age is 310–420 mg/day forP and Ca intakes. (2) CRP and Mg intakes. The analyses were adjusted
al energy, carbohydrate, protein and fat intakes, and Mg intakes for
. Data are adjusted mean ± standard error (SE). A p value of <0.05 was
moderate and high Ca intakes by Bonferroni’s multiple
Levels of intakes Low Med High




Figure 2 Distribution of high CVD risk patients according to Ca and Mg intakes. CRP >3 mg/L defined as high CVD risk. Data are presented
as percent (%).
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present study, the average Mg intakes in older men and
women with diabetes were 253 and 189 mg, respectively.
Furthermore, our data showed that the Mg intake in 80%
of older men and 94% of older women with diabetes was
lower than RDA. The data from the NAHSIT 2005–2008
showed that the average Mg intakes in men and women
over 65 years were 279 and 227 mg, respectively [46].
These findings indicate that 87% of elderly men and 93%
of elderly women did not meet RDA for Mg [46]. Further-
more, the data from the NHANES 2005–2008 showed
that the majority of the Americans over 50 years of age
(55%–70%) did not meet the estimated average require-
ment (EAR) for Mg [43]. The data obtained in the present
study suggest that, similar to most of the elderly people,
the intakes of Ca and Mg in the majority of older patients
with diabetes are low. Thus, recommendation for im-
provements in the dietary Ca and Mg intakes to achieve
adequate intakes for the purpose of reducing CVD risks is
important for older patients with diabetes.
Inappropriate Ca intake and CVD risk
Inappropriate Ca intake may be linked to triggering of
an inflammatory response, which has been implicated in
the pathogenesis of CVD [11]. Low Ca intake affects the
development and outcome of CVD [47]. However, the
effect of increased Ca intakes by consuming dietary Ca
or Ca supplements on CVD risks remains controversial
[10,11,22]. The data obtained in the present studyshowed that older patients with diabetes consuming
diets with low level of Ca had higher CRP level, which
may contribute to high CVD risks. Moreover, one of the
major findings of the present study is that diets with
high level of Ca may also cause high CVD risks unless
consumed with an adequate amount of Mg (Mg in-
takes ≥ RDA for Mg; Taiwan RDA for Mg for healthy
individuals above 65 years of age is 350–360 mg/day for
men and 300–310 mg/day for women). Conversely, in-
take of diets with moderate amount of Ca reduces CVD
risks in older patients with diabetes. Zemel et al. indi-
cated that dietary Ca suppresses oxidative and inflamma-
tory stress [19]. Another study demonstrated that
increased Ca intakes decreased the risk of CVD [21]. In
contrast, a prospective study showed that an increase in
the dietary Ca intakes or Ca supplements increased
myocardial infarction risk [22]. Therefore, Ca may be a
double-edged sword. A deficiency of Ca may evoke
increased secretion of parathyroid hormone, which in-
creases bone resorption, thereby removing Ca from the
bones, and excess of Ca is associated with many inflam-
matory and degenerative diseases [47]. Thus, low Ca
intakes may increase CVD risks and bone loss, whereas
excess Ca intakes may lead to Ca deposition in the arteries
or vascular calcification, and could therefore increase the
risks of CVD [11]. The findings of the present study and
those from several previous studies suggest that high or
low Ca intakes may increase the risks of CVD. Therefore,
it is important to recommend a diet with moderate
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diabetes. It might be beneficial to suggest a range corre-
sponding to “moderate” Ca intakes of 402–600 mg/day
(approximately 67%–100% of Taiwan RDA for Ca).
Inadequate Mg intake and CVD risk
Low Mg intakes are also closely correlated to increased
inflammation and CVD risks [12,13]. In the present
study, patients whose Mg intake was below RDA had el-
evated CRP levels, which may be related to a high risk of
CVD. A nationally representative cross-sectional survey
showed that the Mg intakes in a total of 68% of the
American adults were below RDA, which may result in
increased CRP level and contribute to CVD risks [12]. In
middle-aged people with poor quality of sleep, a low
serum Mg level was reported to be correlated to in-
creased chronic inflammatory stress that could be allevi-
ated by increasing the Mg intake [18]. In the Chinese
population with diabetes, patients with macrovascular
complications had lower serum Mg level than those with
no macrovascular complications [16], and hypomagnes-
emia was arryhtmogenic [17]. In rodents, the intake of
Mg-deficient high-fat diet led to alterations in the
insulin-signaling pathway and increased insulin resistance
[15]. Moreover, diabetic rats showed extensive cardiac re-
modeling and decreased myofibrillar Ca sensitivity, con-
sistent with the observed increases in the phosphorylation
of troponin I [48]. Inadequate Mg intakes may cause a
decrease in the extracellular Mg, leading to the influx of
Ca into the cells, which could trigger the release of pro-
inflammatory cytokines and acute phase proteins from
leukocytes, macrophages, and adipocytes [28,49]. Proin-
flammatory cytokines are released into the bloodstream
and promote the release of CRP from the liver, which
could result in an inflammatory response, platelet aggre-
gation, and endothelial dysfunction, and may ultimately
contribute to the development of CVD and metabolic
disorder [28,49]. The data obtained in the present study
showed that low Mg intakes are associated with high
CVD risks. Thus, improvements in the dietary Mg intakes
should be recommended for older patients with diabetes
to achieve RDA for Mg and thereby reduce CVD risks.
Dietary Ca:Mg intake ratio and CVD risk
Systemic inflammatory activity plays a key role in the
pathogenesis and progression of CVD and type 2 dia-
betes [4]. Inflammatory biomarkers may therefore be a
valuable tool in the evaluation of CVD risk. Among the
inflammatory markers, CRP is considered to be the most
well-validated and standardized marker for the evalu-
ation of CVD risks [37,50]. In addition, increased
leukocyte count, platelets, and RDW are also correlated
to inflammation and cardiovascular complications in pa-
tients with type 2 diabetes [38-40]. In the present study,we analyzed these inflammatory markers to determine
the effects of dietary Ca and Mg intakes on CVD risks in
older patients with type 2 diabetes. Our findings showed
that a diet with a Ca:Mg intake ratio of <2.0 or >2.5 may
increase the risks of CVD in older patients with diabetes.
In contrast, patients maintaining a dietary Ca:Mg intake
ratio of 2.0–2.5 had lower levels of CRP, leukocytes,
platelets, and RDW. Moreover, in the group of patients
with a Ca:Mg intake ratio of 2.0–2.5, there was a lower
proportion of patients with ≥2 high inflammatory
markers, when compared with the other groups. These
findings are in line with the recent Chinese population
based cohort study [24]. Dai et al. found that the Ca:Mg
intake ratio had significant modifying effects on CVD
risks, when compared with the intakes of Mg or Ca
alone [24]. Among the participants with Ca:Mg intake
ratios >1.7, the intakes of Ca and Mg were associated
with reduced risks of total mortality and mortality due
to coronary heart diseases. Conversely, among the par-
ticipants with a Ca:Mg ratio ≤ 1.7, the intake of Mg was
associated with increased risks of total mortality and
mortality due to CVD [24]. The data from the USDA
food surveys from 1977 through 2008 revealed that the
dietary Ca intakes have increased significantly than the
dietary Mg intakes. Furthermore, the Ca:Mg intake ratios
were found to increase from <2–3 in 1995 to ≥3.0 after
2000, coinciding with a rise in the age-adjusted type 2
diabetes incidence from 3.3% to >4.5% and age-adjusted
prevalence rate increase from 4.7% to >6.2% in the
American population [25]. It has been suggested that the
Ca:Mg intake ratio should not be >2.0 from both foods
and supplements. This suggestion is consistent with one
of our major findings that a dietary Ca:Mg intake ratio
of 2.0–2.5 is optimal for reducing CVD risks in older pa-
tients with diabetes. The findings of the present study and
those of some previous studies indicate that a Ca:Mg in-
take ratio between 1.7 and 2.5 may be required to reduce
CVD risk. In general, inadequate Ca and/or Mg intakes
are correlated to inflammation and CVD risk [11,28,49].
Our data suggest that dietary Ca:Mg intake ratio is related
to the markers of inflammation and cardiovascular
complications in older patients with diabetes. An optimal
dietary Ca:Mg intake ratio for reducing CVD risks in older
diabetes patient may be 2.0–2.5.
Ca and Mg intakes and CVD risk
Ca interacts and naturally antagonizes Mg in the absorp-
tion from the intestinal tract into the bloodstream
[23,51]. Therefore, different dietary Ca:Mg intake ratios
alter the absorption of Mg or Ca alone, and diets with
low amount of Mg and high or low amount of Ca may
cause high CVD risk. Indeed, our data indicated that low
Mg and high or low Ca intakes were more prevalent in
our high CVD risk patients than moderate to high Mg
Huang et al. Cardiovascular Diabetology 2014, 13:120 Page 8 of 10
http://www.cardiab.com/content/13/1/120and high or low Ca intakes (65.7% vs. 31.5%). Interest-
ingly, our data also showed that the majority of these
high CVD risk patients (97.1%) consumed high or low
amount of Ca. In contrast, the percentage of high CVD
risk patients whose Ca intake was moderate was only
2.9%. Furthermore, among the 25 patients whose Ca
intakes were >1000 mg/day, only 4 had low CVD risks
(CRP <1 mg/L). Among these 4 patients, 3 consumed
high amount of Mg and maintained a dietary Ca:Mg in-
take ratio of 2.0, 2.7, and 3.3, respectively. Among the
other 21 patients whose Ca intakes were >1000 mg/day
and CRP >1 mg/L, 5 and 16 patients had dietary Ca:Mg
intake ratios of 2.9–3.6 and >4.7. Moreover, our findings
showed that dietary Ca:Mg intake ratios in the low,
moderate, and high CVD risk groups were 2.1 ± 1.3, 2.8 ±
1.8, and 3.0 ± 1.8, respectively (p = 0.016), indicating that
inappropriate Ca and/or Mg intakes and Ca:Mg intake
ratios may increase inflammation and CVD risks. Older
persons with diabetes are at high risk for CVD [2,3] and
inadequate Mg intakes are common in older persons [27].
High or low Ca intake may intensify the response to
subclinical Mg deficiency, leading to increased CVD risk
[13,28]. The results obtained in the present study suggest
that consumption of moderate amount of Ca and ad-
equate amount of Mg as well as maintenance of a Ca:Mg
intake ratio of 2.0–2.5 are important for reducing CVD
risks in older patients with diabetes. In addition, if patients
could achieve an adequate dietary Ca intake of approxi-
mately ≥1000–1200 mg/day by taking Ca supplements,
then, to maintain a Ca:Mg intake ratio of 2.0–2.5 for redu-
cing CVD risks, they may either have to decrease the Ca
intake or increase the Mg intake.
Policy implications for medical care
Our findings raise issues that may have policy implica-
tions for medical care in older patients with diabetes. It
has been established that low Ca and/or low Mg intakes
could increase the risks of inflammatory responses and
CVD [10-12]. As the majority of older patients with
diabetes consume low amount Ca and Mg, constructive
strategies are needed to help these patients to achieve
moderate Ca intake and adequate Mg intake through diet
or supplements. Moreover, medical care practitioners
should counsel patients on a more judicious dietary in-
take to avoid excess Ca consumption. In addition, the
findings of the present study and those of previous studies
suggest an optimal dietary Ca:Mg intake ratio of 2.0–2.5
for reducing CVD risks. RDA was established to meet the
needs of 97%–98% of healthy individuals. According to
RDA for the elderly population above 65 years of age, the
Ca:Mg intake ratio ranges from 2.1 to 3.1 for men and
from 2.4 to 4.1 for women [43-45]. Unfortunately, RDA
provides an average value and does not establish the opti-
mal balance of Ca:Mg intake ratio. Moreover, the majorityof elderly people consume inappropriate amount of Ca
and Mg, particularly, high amount of Ca and low amount
of Mg through diet as well as Ca supplements, which
could result in an inappropriate Ca:Mg intake ratio of >4,
leading to an elevated risk of CVD. Hence, further studies
on the current RDA for Ca and Mg are necessary.
Limitations
While the results of the present study shed light on the
effects of dietary Ca and Mg intakes on the risks of CVD
in older patients with diabetes, there are several limi-
tations to this study. First, the assessments of dietary
intake and lifestyle data were highly dependent on the
self-reported questionnaire. Therefore, overestimation,
underestimation, or poor recall might have produced
confounded results. Fortunately, these older patients with
diabetes lived in rural areas, and thus, most of them had
simple lifestyle and eating behaviors, which increased the
effectiveness of the dietary survey. Second, the sample size
was somewhat small, which may have reduced the statis-
tical power of the subgroup analysis. Thus, to observe the
effects of different dietary Mg and Ca intake levels on
CVD risk, a larger sample size is required. Third, our
current data showed that high or low Ca intake increased
CVD risks, and suggested that moderate Ca and adequate
Mg dietary intakes with a Ca:Mg intake ratio of 2.0–2.5
are important for preventing CVD in older patients with
diabetes. These findings are in line with those reported by
other studies [24,25]. The present findings may also be ap-
plicable to non-rural patient populations with type 2 dia-
betes and healthy adults. However, further studies are still
needed to more accurately assess the role of dietary Mg
and Ca intake in inflammatory response and CVD risk in
other populations. In addition, further studies are required
to establish whether a dietary intervention with optimal
Ca and Mg intakes, as described earlier, would have a
meaningful impact on CVD risks, and whether the effects
of dietary Mg and Ca intakes on inflammatory stress and
CVD risks could also be applied in the investigation of
other diseases such as osteoporosis and cancer.
Conclusions
High or low calcium intake was found to increase CVD
risks in older patients with type 2 diabetes. A balanced
dietary Mg and Ca intake is highly recommended, which
could be a key in reducing inflammatory responses and
CVD risks. Our data suggest that (1) consuming “mo-
derate” amount of 402–600 mg Ca/day (approximately
67%–100% of Taiwan RDA for Ca), (2) consuming
adequate amount of Mg (or meeting RDA for Mg for
healthy individuals above 65 years of age), and (3)
maintaining a Ca:Mg intake ratio of 2.0–2.5 are im-
portant for reducing CVD risks in older patients with
diabetes.
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